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Activating transcription factor 3 (ATF3) belongs to the ATF/cyclic AMP responsive element
binding family of transcription factors and is often described as an adaptive response gene
whose activity is usually regulated by stressful stimuli. Although expressed in a number of
splice variants and generally recognized as a transcriptional repressor, ATF3 has the ability
to interact with a number of other transcription factors including c-Jun to form complexes
which not only repress, but can also activate various genes. ATF3 expression is modulated
mainly at the transcriptional level and has markedly different effects in different types of
cell. The levels of ATF3 mRNA and protein are normally very low in neurons and glia but
their expression is rapidly upregulated in response to injury. ATF3 expression in neurons is
closely linked to their survival and the regeneration of their axons following axotomy, and
that in peripheral nerves correlates with the generation of a Schwann cell phenotype that
is conducive to axonal regeneration. ATF3 is also induced byToll-like receptor (TLR) ligands
but acts as a negative regulator ofTLR signaling, suppressing the innate immune response
which is involved in immuno-surveillance and can enhance or reduce the survival of injured
neurons and promote the regeneration of their axons.
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INTRODUCTION
It has long been known that the ability of peripheral axons to
regenerate is fundamentally greater than that of axons in the brain,
spinal cord,or optic nerves (early literaturewas reviewed inRamon
y Cajal, 1928). One factor that contributes to the successful regen-
eration of the axons in peripheral nerves is the complex cell body
response the neurons show to axotomy. That transcription factors
must play an important role in enabling neurons to regrow their
axons is implicit to the observation that several hundred genes are
regulated in neurons during axonal regeneration (Costigan et al.,
2002; Boeshore et al., 2004). In addition, similarly large numbers
of genes are regulated in the non-neuronal cells present in injured
peripheral nerves, especially Schwann cells (Barrette et al., 2010).
Of the transcription factors that regulate these changes in gene
expression, the function of c-Jun is the best understood. However,
activating transcription factor 3 (ATF3), also known as LRF-1,
LRG-21, CRG-5, and TI-241, is also upregulated in most of the
neurons (Figure 1) as well as in Schwann cells that express c-Jun.
Indeed, ATF3 has become a standard marker for neurons axo-
tomized by peripheral nerve injury (Tsuzuki et al., 2001;Yamanaka
et al., 2005;Yano et al., 2008;Linda et al., 2011) and its expressionby
injured neurons is closely correlated with a regenerative response.
None the less, surprisingly little is known about the functions of
ATF3 in neurons or glia within the injured nervous system, espe-
cially when compared with those of its potential binding partner,
c-Jun.
THE ATF/CREB FAMILY
Activating transcription factor 3 belongs to the ATF/cyclic AMP
responsive element binding (CREB) family of transcription
factors, characterized by a basic region leucine zipper (bZip)motif.
The basic region is necessary for binding to theATF/CREpromoter
DNA sequence (TGACGTCA), and the leucine zipper element
for homo- and hetero-dimerization with other bZip proteins to
differentially regulate transcription. Within this relatively large
family there are a number of subgroups which have been classi-
ﬁed according to their level of homology both within and outside
the bZip domain. Between subgroups, however, there is very lit-
tle similarity outside the bZip domain (Hai and Hartman, 2001).
None the less, some ATF/CREB members can form heterodimers
with members of other families (e.g., C/EBP and Maf families), as
well as with various other ATF/CREB proteins (Thompson et al.,
2009).
The ATF3 gene
Full-length ATF3 was originally isolated from a serum-induced
HeLa cell cDNA library using a DNA probe (Hai et al., 1989). The
ATF3 gene is on chromosome1q32.3 and spans∼56 kb, technically
comprising six exons (see Figure 2). In vitro experiments suggest
that the human ATF3 gene has two promoters, with the most
recently identiﬁed alternate promoter (labeled P1 in Figure 2)
being some ∼43.5 kb upstream from the established canonical
promoter (labeled P2 in Figure 2). This novel promoter appears to
be highly conserved between human and mouse (Miyazaki et al.,
2009). There are al multiple P1 transcription start sites. Using
RNAi against P1 and P2 transcripts, Miyazaki and colleagues were
able to show that P1 activity was dominant in cancer cells express-
ing ATF3 in response to serum, whilst P2 activity was dominant
in cells expressing oncogenic hRas. This alternate promoter usage
is intriguing, not least because the variant transcripts give rise to
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 7 | 1
Hunt et al. ATF3 and the nervous system
FIGURE 1 | Activating transcription factor 3 (ATF3) is expressed in
axotomized, regeneration-competent neurons. (A) ATF3 (green) is
concentrated in the nucleus of a lumbar motor neuron (arrowed) from an
adult rat 14 days following sciatic nerve transaction. This type of cell
regenerates its axon vigorously following nerve injury. Neuroﬁlament
immunoreactivity (red) has been used to show neuronal cytoplasm. The
scale bar also applies to (D). (B) ATF3 (green) is present in the nuclei of
preganglionic parasympathetic neurons in the dorsal nucleus of the vagus
(outlined with a dashed line) and in motor neurons of the hypoglossal
nucleus (asterisk) 5 days after crush injury to the vagus and hypoglossal
nerves in an adult rat. These neurons also regenerate axons following
injury. CD11b immunoreactivity (red) shows reactive microglia around the
axotomized neurons. The scale bar also applies to (C). (C,D) Show the
results of an experiment where a peripheral nerve graft was implanted into
the cerebellum of an adult rat, axotomizing both deep nucleus neurons
and Purkinje cells. Fourteen days after grafting, ATF3 (green) can be seen
in the nuclei (arrows) of neurons within a cerebellar deep nucleus in (D)
but not in the nuclei of Purkinje cells, arrowed in (C). Deep nucleus
neurons regenerate axons into grafts in the cerebellum but Purkinje cells
do not do so; ATF3 is expressed only by the neurons which mount a
regenerative response to axotomy. Neuroﬁlament and calbindin
immunoreactivity (red) has been used to identify Purkinje cells.
the same protein. The variant 5′UTR sequences may be important
in the regulation of translation; Miyazaki et al. (2009) reported
that the structure of the 5′UTRs of the P1 transcripts, as well as
the differential use of transcription start sites appears to affect the
level of translation in response to stress. There was evidence for
the constitutive activation of P1 in two cancer cell lines, LNCaP
and Hodgkin L428.
Alternative mRNA splicing and protein isoforms
Numerous splice variants have been reported which give rise to
truncated forms of ATF3 (see Figure 2). The ﬁrst described vari-
ant results in a protein termed ATF3Δzip owing to its loss of
the carboxy-terminal leucine zipper dimerization domain (Chen
et al., 1994). The resultant protein is truncated at 118 aminoacids
(118aa). The expression of two other splice variants of ATF3 was
demonstrated by using RT-PCR on cDNA from primary human
umbilical vein endothelial cells treatedwith the calcium ionophore
A23187 (Hashimoto et al., 2002). Somewhat surprisingly, although
these two variant transcripts were abundant, ATF3Δzip was not
detectable in this system. Subsequent analysis of the two novel
variant transcripts revealed that they both gave rise to the same
protein isoform, truncated at the carboxy terminus and lacking
the leucine zipper dimerization domain. The authors have termed
the variant transcripts ATF3Δzip2a and ATF3Δzip2b, and their
common 135aa protein ATF3Δzip2 (which shares its ﬁrst 115aa
with full-length ATF3).
TwonovelATF3mRNA isoformshave beendescribed inhuman
HepG2 hepatoma cells undergoing metabolic stress (Pan et al.,
2003); both were detected by RT-PCR. The ﬁrst- ATF3Δzip2c –
gives rise to a 106aa protein and is identical to the ATF3Δzip2
isoform except for a further truncation of 29aa near the N termi-
nus. The second splice variant, termed ATF3Δzip3, is similar to
the ATF3Δzip2b splice variant. However, it retains the sequence
between exons C and D′, which the authors term C′; this intro-
duces an early in-frame stop codon, giving rise to a 120aa protein
truncated at the carboxy terminus. Interestingly, Pan et al. did not
detect expression of ATF3Δzip, ATF3Δzip2a, or ATF3Δzip2b in
HepG2 cells.
Finally, an ATF3 mRNA splice variant termed ATF3b has been
identiﬁed in αTC1.6 cells, which results from splicing of 106 bases
within exon B (Wang et al., 2003). An early in-frame stop codon
is introduced at the site corresponding to position 10 in the ATF3
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FIGURE 2 | Activating transcription factor 3 (ATF3) gene and protein
structure. (A) A schematic representation of ATF3 gene structure and
transcript splice variants. The human ATF3 gene spans approximately 56 kb on
chromosome 1q32.3, and comprises six exons. This schematic adopts the
exon nomenclature used by other research groups (Hashimoto et al., 2002;
Pan et al., 2003; Hartman et al., 2004). The start codon, denoted by the letter
“s,” is located within exon B. The respective in-frame stop codons are
denoted by “∗” within each transcript. Note that the two transcripts which
give rise to full-length ATF3 use different promoters, P1 and P2, and vary only
in their 5′ untranslated region owing to the incorporation of exon A-1 or A,
respectively. P1 is non-canonical, lying some ∼43.5 kb upstream of P2, and
was only recently described (Miyazaki et al., 2009). Note that exons B1 and
B2 in ATF3ΔZip2c are not the same as those annotated B1 and B2 in ATF3b;
the respective spliced fragments of exon B are of different sizes and use
different splice donor and acceptor sites. Exons are not shown to scale. (B)
The predicted protein structure for each of the ATF3 mRNAs is shown in (A),
with the activation, repression, basic, and leucine zipper regions designated.
Modiﬁed from Pan et al. (2003). aa, Amino acids.
amino acid sequence. However, there is another in-frame start
codon downstream which, if used for initiation of translation,
gives rise to a 124aa ATF3 isoform. The authors report that this
protein, which is truncated at the amino terminus, can be detected
in whole pancreas homogenate.
Structure/function relationship for ATF3 protein isoforms
Full-length ATF3 comprises 181aa, with a molecular mass of
22 kDa (Hai et al., 1989; Chen et al., 1994; Thompson et al., 2009).
The region between 40aa and 84aa is thought to exert transcrip-
tional repression (Hsu et al., 1992), whilst the basic region leucine
zipper domain, spanning the region from 88 to 147aa is neces-
sary for dimerization and DNA binding (Hashimoto et al., 2002).
ATF3Δzip and ATF3Δzip2 are truncated at 118aa and 135aa,
respectively.
Somewhat paradoxically ATF3Δzip, a 14-kDa protein, is
thought to have the capacity to activate transcription despite
retaining the putative transcriptional repression domain and lack-
ing most of the basic region leucine zipper domain. This may be
achieved by ATF3Δzip sequestering inhibitory co-factors (Chen
et al., 1994). Hua et al. (2006) also reported that ATF3Δzip2
displaces the positive cofactor CBP/300 from a protein complex
involved in the transcriptional control at nuclear factor-κB (NF-
κB) sites in the anti-apoptotic gene cIAP2. The same ATF3Δzip2
protein modulates the activity of the full-lengthATF3 protein dur-
ing stress responses and cellular proliferation (Hashimoto et al.,
2002). ATF3Δzip3 stimulates transcription from the asparagine
synthetase promoter (Pan et al., 2003); as with the transcriptional
activation effects of ATF3Δzip, this may be mediated through a
sequestration of co-repressors away from the promoter.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 7 | 3
Hunt et al. ATF3 and the nervous system
Finally, the 124aaATF3b isoform (with N-terminal truncation)
can still form homodimers, despite lacking the weak activation
region and part of the repression region. These ATF3 homod-
imers can bind to the CRE/ATF site of the proglucagon promoter
and stimulate transcription (Wang et al., 2003). It is worth noting
that the prevalence and signiﬁcance in vivo of the products of the
numerous splice variants of ATF3 have not yet been fully estab-
lished. In particular, almost nothing is known about the expression
in the nervous system of the protein products of splice variants.
ATF3 INDUCTION AND REGULATION
Activating transcription factor 3 has been variously described as
an immediate early gene, a stress inducible gene and an adap-
tive response gene (Thompson et al., 2009; Zmuda et al., 2010).
It appears to play an important role in mediating the cellular
response to injury and stress, but there are microarray data to
show that ATF3 also enables cells to cope with intracellular and
extracellular changes which are not directly harmful (Hai, 2006).
In most healthy tissues ATF3 is expressed at a very low level, if at
all (Hsu et al., 1991; Chen et al., 1994; Allen-Jennings et al., 2001).
The regulation of ATF3 appears to take place mainly at the
translational level: there is no evidence that its activity is regu-
lated by phosphorylation as is that of c-Jun or STAT3, for exam-
ple, whose expression by neurons is also correlated with axonal
regeneration. Analysis of the ATF3 promoters reveals an array of
transcription factor binding sites consistent with its expression
being induced by stressful stimuli and other factors. P2 contains
a canonical TATA box, inducible transcription factor binding sites
(e.g., for ATF/CRE, AP-1, and NF-κB), and cell cycle dependent
sites (e.g., for E2F and Myc/Max). The alternate promoter P1 con-
tains a non-canonical TATA box as well as ATF/CRE, AP-1, p53,
E2F, and NF-κB binding sites. As would be expected, c-Jun/AP-1,
ATF2, ATF4, ATF6, CREB, Myc, C/EBPB, Erg-1, and other tran-
scription factors have all been shown to induce ATF3 expression
(Tamura et al., 2005; Huo et al., 2006). In addition,ATF3 represses
its own expression (Wolfgang et al., 2000), limiting the period of
its expression in response to stressful stimuli.
The co-expression of c-Jun and ATF3 in the nervous sys-
tem following traumatic injury and other stressful stimuli makes
c-Jun a prime candidate for controlling ATF3 transcription.
ATF3 expression is upregulated by c-Jun in rabbit reticulocytes
(Weidenfeld-Baranboim et al., 2009), human vascular endothelial
cells (Weidenfeld-Baranboim et al., 2009), and neuronal cell lines
(Jankowski et al., 2009) but elevation of c-Jun does not appear to
be a prerequisite for ATF3 upregulation in human skin ﬁbroblasts
(Abe et al., 2003) and primary sensory neurons (Tsujino et al.,
2000). Another factor in the control of ATF3 induction is Jun
Dimerization Protein 2 (JDP2), a ubiquitous bZip protein closely
related to ATF3, which exerts its effect at the ATF/CRE and two
non-canonical auto-regulatory sites, at −90 and −20, of the ATF3
promoter (Kim et al., 2010b). JDP2 represses ATF3 expression
and its ablation results in the potentiation of ATF3 expression
by stressful stimuli (Weidenfeld-Baranboim et al., 2009). Interest-
ingly, phosphorylation of JDP2 has been observed in response to
such stimuli, but the signiﬁcance of this remains unclear.
Studies with siRNA have shown that the transcription factor
SOX11 (Jankowski et al., 2009), a member of the group C SOX
(SRY-related HMG-box) transcription factor family, positively
regulates ATF3 expression in axotomized sensory neurons in vivo.
ATF3 expression in astrocytes is also upregulated at the transcrip-
tional level by NF-E2-related factor 2 (Nrf2), a transcription factor
which binds to the antioxidant response element (ARE) in pro-
moters. Treatment with Nrf2 activators and oxidants provokes
ATF3 induction in astrocytes, and ATF3 expression is reduced in
Nrf2-depleted cells (Kim et al., 2010b). Phosphorylation of the α
-subunit of the eukaryotic translation initiation factor 2 (eIF2) in
lung cells in response to hypoxia leads to nuclear translocation of
ATF4 and a subsequent increase in ATF3 expression (Konsavage
et al., 2012).
If extracellular signals are to increase ATF3 expression, sig-
nal transduction mechanisms between the cell membrane and
the DNA must be activated. Mitogen-activated protein kinase
(MAPK) pathways are involved in the cellular response to many
external stimuli. Of theseMAPKpathways, the p38 pathway, extra-
cellular signal-regulated kinase (ERK), and the c-Jun N-terminal
kinase (JNK) pathways are known to affect ATF3 (Figure 3).
ATF3 expression is upregulated by both ATF2 and c-Jun, and both
of these are phosphorylated by MAPK pathways. For example,
the induction of ATF3 expression in colonic cancer cells treated
with tolfenamic acid, a pro-apoptotic drug, is mediated by p38
activation leading to phosphorylation of ATF2 and involves the
ATF/C/EBP-binding site in the ATF3 promoter (Lee et al., 2010).
The p38 pathway, but not the ERK nor the JNK pathways, was
also required for ATF3 expression in several cell lines exposed
to anisomycin (Lu et al., 2007). However, JNK activation may
also be associated with ATF3 induction in cultures of primary
sensory neurons (DRG and nodose ganglion cells); inhibitors of
JNK reduced c-Jun phosphorylation,ATF3 upregulation, and neu-
rite outgrowth (Lindwall et al., 2004). As those authors pointed
out, it is tempting to construct a pathway involving JNK acti-
vation leading to c-Jun phosphorylation and the ATF3 upregu-
lation but some neurons showed elevated ATF3 without pc-Jun
or pJNK (Lindwall et al., 2004). The retrograde axonal transport
of JNK by neurons appears to be an important part of the sig-
naling mechanism by which an injured axon induces a cell body
response, including the upregulation of ATF3 (Lindwall andKanje,
2005). However, MAPK activation is not essential for upregu-
lation of ATF3, at least in non-neuronal cells (Konsavage et al.,
2012).
Activating transcription factor 3 expression is induced by acti-
vation of the innate and adaptive immune systems. Toll-like
receptor (TLR)3, TLR4, and TLR9 agonists are potent inducers
of ATF3 expression in macrophages and epithelial cells (Gilchrist
et al., 2006; Suganami et al., 2009; Roussel et al., 2011) as is TCR
ligation in CD4 lymphocytes (Gilchrist et al., 2008). TLR acti-
vation stimulates the JNK and p38 MAPK pathways and NF-κB
activation.
Apart from transcriptional regulation, there is now evidence
that the expression of ATF3 is regulated at the post-transcriptional
level by selective degradation. Double minute 2 (MDM2) is an E3
ubiquitin ligase for ATF3 and regulates ATF3 expression by pro-
moting its degradation, at least in HCT116 (colorectal carcinoma)
cells andmouse embryonic ﬁbroblasts (Moet al., 2010). It is not yet
clear how signiﬁcant this form of regulation is in injured neurons,
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FIGURE 3 | Diagram showing the induction of ATF3 in a neuron by
different stimuli and its effect on some targets relevant to axonal
regeneration.The pathways inducing ATF3 expression include
axotomy, receptor protein tyrosine kinase stimulation, synaptic NMDA
receptor activation and endoplasmic reticulum stress. ATF3 is shown
repressing its own expression and that of inﬂammatory cytokines (IC)
and, with other AP-1 factors, activating transcription of c-Jun, SPRR1A,
and hsp27.
however, where there is a close correlation between ATF3 mRNA
levels and nuclear ATF3 protein (Tsujino et al., 2000).
INTERACTIONS WITH OTHER TRANSCRIPTION FACTORS
AND GENERAL FUNCTIONS OF ATF3
The interaction of ATF3 with many other transcription factors
dramatically alters its effects on transcription (reviewed by Hai,
2006). ATF/CREB members can form heterodimers with mem-
bers of other families (e.g., C/EBP and Maf families), as well as
with other ATF/CREB subgroup members. c-Jun is a particularly
important partner for ATF3 in the nervous system; as well as being
a potential inducer of ATF3 expression, c-Jun binds to ATF3.
c-Jun co-immunoprecipitates with ATF3 in extracts of reticulo-
cytes (Hai and Curran, 1991), PC12 cells (Nakagomi et al., 2003;
Pearson et al., 2003), Neuro-2a cells (Pearson et al., 2003),
suggesting that these two transcription factors can form het-
erodimers, at least in non-neuronal cells and “neuronal” cell lines.
Importantly, both ATF3 and c-Jun are present in hypoglossal neu-
rons after their axon was cut (Kiryu-Seo et al., 2008). Here, an
unconventional mechanism of action for ATF3 and c-Jun has
been proposed, in which the constitutively expressed transcrip-
tion factor Sp1 (a member of the Sp/KLF family) acts as scaffold
protein to bring about the association of ATF3, c-Jun, and STAT3
at the Sp1 binding sites. This notion is supported by the coim-
munoprecipitation of ATF3 and c-Jun, ATF3 and Sp1, c-Jun and
Sp1, and STAT3 and Sp1, but not STAT3 and c-Jun (or ATF3;
Kiryu-Seo et al., 2008). A transient upregulation of JunB has
been reported in axotomized neurons (Kenney and Kocsis, 1997),
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making ATF3/JunB heterodimers another possible combination
regulating axonal regeneration.
It has been suggested that in regenerating liver, ATF3 in com-
bination with c-Jun activates speciﬁc promoters containing AP-1
and CRE sites, but in combination with JunB it potently represses
activation of AP-1 sites (Hsu et al., 1992). ATF3 has been impli-
cated in the cellular response to many varied insults, including
ischemia/reperfusion of the kidney or heart (Chen et al., 1996; Yin
et al., 1997), liver damage (Chen et al., 1996), ventilation–induced
lung damage, and many types of insult to cultured cells including
hypoxia (Ameri et al., 2007) and other treatments (Lerner et al.,
1996). Many circumstances that cause ATF3 expression also lead
to cell death (Kim et al., 2010a; Liu et al., 2011) but ATF3 has also
been found to be constitutively expressed in a number of human
cancers and it is said to be associated with metastatic potential.
The interaction of ATF3 with p53 is thought to facilitate apoptosis
(Yan et al., 2005). It is believed that ATF3 stabilizes the p53 pro-
tein through blocking MDM2-mediated ubiquitination, nuclear
export, and degradation. Protein deletion studies reveal that the
102–139aa region of ATF3 is necessary for p53 binding.
Activating transcription factor 3 is believed to have at least two
key roles: as a mediator of the cellular stress response, and as a
regulator of cellular proliferation. However, because the functions
of ATF3 depend on the transcriptional milieu within which it is
found, ATF3 can have opposite effects on different types of cell
(Yin et al., 2008). Both gene delivery (Mashima et al., 2001) and
gene inactivation experiments (Nawa et al., 2002) have attributed
pro-apoptotic effects to ATF3, yet anti-apoptotic effects have also
been described (Kawauchi et al., 2002). Similarly, ATF3 has been
reported to suppress or promote cell cycle progression (Fan et al.,
2002; Lv et al., 2011). In addition, in recent years its role in immune
response pathways has received much attention, especially as a
negative regulator of TLR family signaling in the inﬂammatory
response (reviewed by Thompson et al., 2009). Network analysis
predicts that ATF3 is part of a transcriptional complex containing
members of the NF-κB family of transcription factors and that
ATF3 can regulate the expression of inﬂammation-related genes
including IL1β, IL6, IL12, TNFα, and CCL4 (Gilchrist et al., 2006).
Hai (2006) proposed thatATF3 induction by various stimuli in dif-
ferent cell types contributes to the control of the cell death and cell
cycle machineries in a context-dependent manner. The nervous
system appears to be a special context in that while ATF3 tends to
produce tissue dysfunction and disease progression in many types
of non-neuronal cells (Hai, 2006), in the nervous system ATF3
appears to contribute to the regenerative response (Campbell et al.,
2005).
One adaptive pathway in which ATF3 has been implicated is
the Endoplasmic Reticulum Stress Response (ERSR; also known
as the Unfolded Protein Response) which occurs in response to
the pathological accumulation of unfolded or misfolded proteins
within the lumen of the endoplasmic reticulum. In essence, this
pathway attempts to restore normal ER protein folding and pro-
cessing through several different actions including the inhibition
of translation and reduction in translocation of new proteins into
the ER, promotion of the export of aberrant proteins from the ER
lumen to the cytosol for degradation, and the recruitment of more
molecular chaperones to assist in protein folding. Ultimately, if the
ER remains stressed, the pathway will instead default to apoptosis.
The ERSR is complex and is mediated by a tripartite system of
transmembrane molecular sensors within the endoplasmic retic-
ulum, namely ATF6, PERK, and IRE1 alpha. Each of these has
a fairly well deﬁned pathway, becoming activated following the
detection of inappropriately folded protein within the ER lumen.
ATF3 has been implicated in the PERK-mediated arm (Figure 3),
which is initially protective but alsohas a role in inducing apoptosis
via the ATF4–ATF3–CHOP cascade (Mungrue et al., 2009).
Pan et al. (2003) have presented evidence to show that ATF3
expression was enhanced in HepG2 hepatoma cells in which the
ERSR pathway had been activated. There are many examples of
ERSR activation in neurodegenerative diseases and following trau-
matic injury to the nervous system, including Parkinson’s disease
(Bellucci et al., 2011) and in vitro models of that condition (Holtz
et al., 2006), amyotrophic lateral sclerosis (Kanekura et al., 2009),
Alzheimer’s disease (Salminen et al., 2009), and following periph-
eral nerve injury (Penas et al., 2011). In many of these cases (but
not apparently Alzheimer’s disease) ATF3 expression is also found
in the affected neurons. However, a causal link between the ERSR
and ATF3 expression usually has not been established and the
effect of ATF3 within the stressed cells is uncertain. Cultured
midbrain neurons treated with 6-OHDA (a model of the neu-
rodegeneration found inParkinson’s disease) showed anERSR and
upregulated ATF3 expression but neurons from ATF3 “knockout”
mice were not protected from cell death following 6-OHDA treat-
ment (Bernstein et al., 2011). This was interpreted as indicating
that the induction of an ERSR and consequent ATF3 expression
was not the pathway leading to cell death in this model (it was
proposed to be neuroprotective instead). However the value of this
mutation for investigating ATF3 function in the nervous system
has been questioned (see below).
ATF3 IN NORMAL AND INJURED NEURONS
INTACT NEURONS
Activating transcription factor 3 is either not expressed or
expressed at very low levels in most intact neurons in vivo. In
some studies ATF3 could not be detected in the neurons of unin-
jured animals. For example, it has been reported that there is no
immunohistochemically detectable ATF3 in the facial motor neu-
rons of intact mice (Parsadanian et al., 2006) and that there is no
signal in Western blots for ATF3 in adult rat cerebral hemisphere
(Yano et al., 2008). Although ATF3 has been detected in the nuclei
of a very small percentage of primary sensory neurons in DRG of
uninjured rats in some studies (Averill et al., 2002), others have
failed to ﬁnd such cells (Tsuzuki et al., 2001; Takahashi et al., 2003;
Carlton et al., 2009).A similar lownumber of sympathetic neurons
with ATF3-positive nuclei have been found in the superior cervi-
cal ganglia of intact rats (Hyatt-Sachs et al., 2007). It seems likely
that ATF3 expression by sensory and postganglionic sympathetic
neurons in intact animals is infrequent enough to be overlooked
in most studies and may reﬂect a low level of axonal injury in
populations of neurons that project to exposed sites.
Cytoplasmic ATF3 has been reported in von Economo neurons
in the anterior cingulate gyrus of primates including man (Stimp-
son et al., 2011); this is quite different from the normal pattern of
ATF3 expression in which the gene is only expressed at times of
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changes in the intracellular or extracellular environment and the
protein is found predominantly in the nucleus. In our experience
cytoplasmic immunohistochemical signal for ATF3 in neurons is
more common in mice than in rats, whereas nuclear staining is
injury-speciﬁc and similar in both mice and rats. Delivery of the
ATF3 gene with an amplicon vector to rat DRG neurons in culture
resulted in both cytoplasmic and nuclear localization of the pro-
tein (Seijffers et al., 2006) in contrast to the nuclear localization of
endogenous ATF3. The same combined pattern was also observed
in vivo with neuronal ATF3 overexpression, with majority neu-
rons showing strong cytoplasmic staining, and a minority, also
nuclear translocation (Seijffers et al., 2007). It has been reported
that STAT1 is necessary for nuclear expression of ATF3 in hepa-
tocytes and pancreatic beta cells (Kim et al., 2009, 2010a). It is to
be hoped that there will be similar studies involving neurons and
glial cells.
ATF3 IS UPREGULATED IN NEURONS PROJECTING INTO INJURED
PERIPHERAL NERVES
The most consistent observation on ATF3 expression in the ner-
vous system is that ATF3 is upregulated by neurons with axons
projecting into injured peripheral nerves, including spinal motor
neurons (Tsujino et al., 2000; Figure 1A), facial motor neurons
(Parsadanian et al., 2006; Shokouhi et al., 2010), primary sensory
neurons (Tsujino et al., 2000; Tsuzuki et al., 2002), postganglionic
sympathetic neurons (Hyatt-Sachs et al., 2007), and preganglionic
parasympathetic neurons (Peddie and Keast, 2011; Figure1B).
ATF3 immunoreactivity in these regenerating peripheral neurons
is concentrated in the nucleus, but not the nucleolus, but cytoplas-
mic immunoreactivity is sometimes detectable. All DRG neurons
with injuries to their peripheral axon appear to express ATF3
mRNA (Tsujino et al., 2000). ATF3 mRNA appears in DRG neu-
rons by 6 h after spinal nerve transection but takes several hours
longer after a more distal sciatic nerve transection (Tsujino et al.,
2000). These observations on the effects of distance between the
site of axotomy and the cell bodies of the injured neurons have
been conﬁrmed (Linda et al., 2011). There are two obvious expla-
nations of the reduced time delay following spinal nerve injury:
the shorter time taken for a retrograde signal to reach the cell bod-
ies after axotomy or the more intense cell body reaction seen after
more proximal axotomy (Lieberman, 1971). In addition, ATF3 is
retrogradely transported in axons of peripheral nerves, as demon-
strated by its accumulation proximal to a ligation (Lindwall and
Kanje, 2005). Transection and crush injuries to peripheral nerve
have been most often used to upregulate ATF3 in peripheral neu-
rons but tetanic stimulation of rat sciatic nerve, which produces
Wallerian degeneration in the nerve, also induces ATF3 expres-
sion in DRG neurons (none was found in naïve rats; Liang et al.,
2010). Less intensive stimulation did not upregulate ATF3 in DRG
neurons (Tsujino et al., 2000; Tsuzuki et al., 2001).
A key feature of the neuronal response to axotomy in DRG neu-
rons is that this response is much more muted following injury of
the central process of their axons. In the case of ATF3, this response
is weaker, conﬁned to larger neurons and more transient, disap-
pearing by 7 days after injury (Huang et al., 2006). None the less,
ATF3 upregulation is one of the more obvious effects of injury to
the central processes of primary sensory neurons.
Neuronal ATF3 is also upregulated in peripheral neuropa-
thy. Paclitaxel, a cytotoxic drug used in the treatment of cancer
is associated with a peripheral neuropathy side-effect, also pro-
duces the upregulation of ATF3 in primary sensory neurons in
DRG and trigeminal ganglia in experimental animals (Jimenez-
Andrade et al., 2006; Peters et al., 2007a). However, ATF3 expres-
sion remained low in animals where no axonal degeneration was
detected (Flatters and Bennett, 2006). A rat model of diabetes,
which induces a peripheral neuropathy, also caused ATF3 upreg-
ulation in some DRG neurons. Injection of resiniferatoxin into
the paws of rats causes a dying-back neuropathy involving noci-
ceptive axons and is associated with ATF3 upregulation in the
DRG neurons during the subsequent period when axonal regen-
eration occurs (Mitchell et al., 2010). Similarly, ATF3 is upregu-
lated in motor neurons in models of amyotrophic lateral sclerosis
(Malaspina et al., 2010) which also involve dying-back of axons.
A plausible explanation of all these results is that each of the pro-
cedures that produce upregulation of ATF3 in neurons, with the
possible exception of NGF-deprivation of sympathetic neurons,
also involves some degree of axonal injury or separation from
targets which, in turn, signals to the cell body to upregulate ATF3.
ATF3 UPREGULATION BY PERIPHERAL NEURONS IN THE ABSENCE OF
DIRECT INJURY
Several treatments that do not involve direct injury to nerve trunks
have been found to induce ATF3 in peripheral neurons. Loss of
NGF support induces ATF3 expression in postganglionic sym-
pathetic neurons (Hyatt-Sachs et al., 2007). In addition, some
treatments which produce peripheral inﬂammation induce ATF3
in neurons. For example, injection of formalin into the footpad of
rats induced an inﬂammatory response in the foot and induced
ATF3 expression in some DRG neurons and even a few motor
neurons in the spinal cord (Tsujino et al., 2000). However, Fre-
und’s complete adjuvant, when injected into the footpad, did not
produce ATF3 upregulation despite the profound inﬂammation
produced at the injection site (Tsujino et al., 2000; Segond von
Banchet et al., 2009; Braz and Basbaum, 2010). Injections of cap-
saicin, formalin,mustard oil, ormenthol into the hind paw of mice
induced expression of ATF3 in distinct subpopulations of sensory
neurons, an observation which was interpreted as showing that
the different agents injured different populations of sensory axons
(Braz and Basbaum, 2010). ATF3 was also upregulated in DRG
neurons in ratmodels of arthritis where the extent of axonal injury
is unknown (Ivanavicius et al., 2007; Christianson et al., 2010).
ATF3 IS UPREGULATED BY SOME TYPES OF CNS NEURONS FOLLOWING
INJURY
Unlike neurons which project into peripheral nerves,most injured
CNS neurons do not regenerate their axons although many pro-
duce local sprouts from their injured axons (Fishman and Mattu,
1993; Zeng et al., 1994; Hill et al., 2001). ATF3 is upregulated
by axotomized intrinsic CNS neurons, but only by some and
only under certain conditions. Among the critical factors that can
reduce ATF3 expression after axotomy appear to be the distance
between the site of axotomy and the neuronal cell body and the
abundance of collaterals proximal to the injury site. These fac-
tors can be difﬁcult to separate in the case of CNS neurons which
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give off collaterals at several points along their length. Cerebellar
Purkinje cells which are particularly poor at regenerating axons
(Anderson et al., 1998; Chaisuksunt et al., 2000) do not upregulate
ATF3 after axotomy (Figure 1C).
Cerebral neocortex and thalamus
Activating transcription factor 3 is upregulated in neurons around
cortical ischemic infarcts and in cortical neurons thought to
project through the damaged region (Ohba et al., 2003, 2004).
The same studies also ﬁnd a transient (lasting a few days) upreg-
ulation of ATF3 mRNA and protein in some thalamic neurons.
ATF3, and several other growth-associated molecules including
GAP43,were not upregulated by corticospinal neurons after spinal
cord injury but they were upregulated after intracortical axotomy
(Mason et al., 2003). Together these results suggest that ATF3 is
upregulated by thalamic projection neurons and by neocortical
projection neurons following axotomy, but only if the injury is
sufﬁciently proximal to the cell body.
Hippocampus
Strong ATF3 expression was identiﬁed in the nuclei of dentate
gyrus neurons following injection of kainate, an excitotoxin (Fran-
cis et al., 2004). Interestingly, the CA1 pyramidal neurons, which
are more susceptible to kainite neurotoxicity, do not upregulate
ATF3 so strongly as dentate neurons. This may suggest that ATF3
expression following excitotoxicity is involved in the survival of
neurons rather than cell death.
Retina
After optic nerve injury (Takeda et al., 2000), retinal ganglion
cells show a stronger and more prolonged upregulation of ATF3
(and other growth-associated molecules; Berry et al., 2008) than
most other CNS neurons. This response may be the result of the
relatively proximal axotomy and/or the lack of collaterals of the
injured axons. Retinal ganglion cells also show a greater capability
for axonal regeneration and a greater susceptibility to cell death
following axotomy than most other CNS neurons (Allcutt et al.,
1984; Campbell et al., 1999, 2003), and these ﬁndings are com-
patible with ATF3 having a role in regulating axonal regeneration
and/or in cell death in response to axonal injury. Raised intraocular
pressure in a rat model of glaucoma also elevates ATF3 expression
in retinal ganglion cells to an extent that correlates linearly with
the degree of injury to their axons (Guo et al., 2009, 2011).
Brainstem
Pontocerebellar neurons show a prolonged (weeks) upregulation
of ATF3 after axotomy (Lovas et al., 2010). The same applies
to dopaminergic neurons in the substantia nigra pars compacta
(Song et al., 2008), and olivocerebellar neurons following axotomy
within the cerebellum (our unpublished observations).
ATF3 IN TREATMENT-STIMULATED, REGENERATING CNS NEURONS
Since most intrinsic mammalian CNS neurons do not regen-
erate their axons (Ramon y Cajal, 1928; Bolsover et al., 2008)
the relationship between ATF3 expression and regeneration can
usually only be studied in models with an artiﬁcially induced
regenerative response. One exception is the mammalian optic
nerve where a very small percentage of axons can regenerate after
injury even without further stimulus (Campbell et al., 1999). The
many treatments claimed to induce axonal regeneration by CNS
neurons include antibodies to myelin proteins (Raineteau et al.,
1999), administration of neurotrophins (Bradbury et al., 1999),
administration of chondroitinase (Bradbury et al., 2002), and the
implantation of olfactory glia (Li et al., 1997). However, a partic-
ularly successful way to induce regeneration of axons of intrinsic
CNS neurons involves the implantation of peripheral nerve grafts
(Richardson et al., 1980), which provide good pro-regenerative
environment.
None the less, even nerve grafts only induce the regenera-
tion of axons of some types of CNS neurons (Anderson et al.,
1998; Anderson and Lieberman, 1999). The neurons that can
be induced to regenerate their axons have always been found to
show a prolonged upregulation of ATF3. Following the implan-
tation of nerve grafts into the thalamus more than 90% of the
neurons that regenerate axons into the graft come from the thal-
amic reticular nucleus (TRN; Morrow et al., 1993), whereas just
few thalamic projection neurons and no corticothalamic neurons
regenerate their axons into the grafts. Interestingly, at early time-
points, such grafts induced the upregulation of ATF3 protein in
many nearby thalamic neurons. However, after 7 days or longer
most of the ATF3-positive nuclei were in TRN neurons that had
regenerated their axons into the grafts (Campbell et al., 2005).
Although the grafts must have axotomized many cortical neurons
near their terminations in the thalamus, cortical neurons were
never ATF3-positive.
Other CNS neurons that can be induced to regenerate axons
into peripheral nerve grafts include retinal ganglion cells, fore-
brain cholinergic neurons, rubrospinal neurons, and those in the
cerebellar deep nuclei. ATF3 upregulation has been reported in
rubrospinal neurons regenerating axons into peripheral nerve
grafts in the cervical spinal cord (Shokouhi et al., 2010) and is also
found in cerebellar deep nucleus neurons that have been stimu-
lated to mount a regenerative cell body response by the presence of
a peripheral nerve graft (Figure 1D). In marked contrast, Purkinje
cells, which never regenerate into such grafts, do not upregulate
ATF3 (Figure 1C) ATF3 upregulation has been reported in retinal
ganglion cells of Zebraﬁsh during axonal regeneration following
optic nerve crush (Saul et al., 2010).
ATF3 UPREGULATION IN NEURONS WITHOUT DELIBERATE AXOTOMY
Trans-synaptic effects of nerve injury
Chronic constriction injury (CCI) of peripheral nerves is a model
of chronic pain (Bennett and Xie, 1988; Vos et al., 1994) which
involves inﬂammation–microglial activation andT-cell invasion–
in the central target regions of the primary nociceptive neurons,
the superﬁcial dorsal horn of the spinal cord or the spinal nucleus
of the trigeminal nerve. Sciatic nerve CCI elevates ATF3 expres-
sion in L4 and L5 dorsal root ganglion neurons (Obata et al.,
2003; which could be due to neuropathic pain and/or axotomy)
but also in the dorsal horn (Latremoliere et al., 2008). At both
sites, ATF3 expression and inﬂammation were attenuated by the
neuroinﬂammation-suppressing minocycline.
Stress and amphetamine administration
The limbic part of the striatum, the nucleus accumbens, is impor-
tant in the responses to psychological stress and the entire striatum
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is an important site of amphetamine action. A nearly 20-fold
increase in ATF3 mRNA expression was produced in the striatum
of adult rats by the stress induced by restraint within a poly-
thene cone for 60min. A non-toxic dose of amphetamine, which
increases dopamine levels in the striatum, also upregulated ATF3
mRNA in the striatum but to a lesser extent (Green et al., 2008).
Methamphetamine also raised ATF3 levels in the striatum of rats
(Jayanthi et al., 2009).
Non-axotomy signals for ATF3 expression in neurons
Activating transcription factor 3 expression may be upregulated
in neurons in response to stimuli similar to those that increase its
expression in non-neuronal cells (see above) including the MAPK
pathways and the ERSR, i.e., extracellular signals and endoplas-
mic reticulum stress. Treatment with an antiserum against NGF
inducesATF3 expression in rodent postganglionic neurons (Hyatt-
Sachs et al., 2007), a result which could be explained by retrograde
transport of NGF suppressing ATF3 expression. A similar effect
had been demonstrated previously in differentiated PC12 cells
(Mayumi-Matsuda et al., 1999).
In vitro, stimulation of synaptic NMDA receptors led to a
neuroprotective effect and ATF3 expression by the postsynaptic
hippocampal neurons. Both effects were blocked by the NMDA
antagonist MK801. Transfection of the neurons with inhibitors
of CREB and CaMKIV showed that this expression of ATF3 was
regulated by a nuclear calcium signaling pathway involving these
molecules (Zhang et al., 2011).
Demyelination of DRG/glial cultures also leads to ATF3 upreg-
ulation by the neurons (Kiryu-Seo et al., 2010). Treatment with
shRNA directed against ATF3 reduced ATF3 expression, decreased
the velocity of mitochondria within demyelinated axons and
increased oxidative damage in the neurons.
ATF3 IN GLIAL CELLS
Injury to the peripheral nervous system induces axonal
regeneration-associated with profound phenotypic changes in
glial and other non-neuronal cells including satellite cells and
Schwann cells. ATF3 is strongly upregulated in peripheral glia fol-
lowing various types of injury. Schwann cells in the distal stump
of injured sciatic nerves in rats and mice upregulate ATF3 (Hunt
et al., 2004; Isacsson et al., 2005; Kataoka et al., 2007; Dahlin
et al., 2008; Saito and Dahlin, 2008) in addition to c-Jun. Glial
cells including Schwann and satellite cells in the superior cervi-
cal ganglion expressed ATF3 after decentralization (section of the
cervical sympathetic trunk); this procedure induces the antero-
grade degeneration of preganglionic ﬁbers and some of the ATF3
expression was probably around degenerating ﬁbers (Zigmond
andVaccariello, 2007). There was a suggestion that satellite cells in
DRG upregulate ATF3 following injury to the sciatic nerve (Isac-
sson et al., 2005; Hu et al., 2007) but this has not been generally
reported, perhaps because the expression is weaker than in the
sensory neurons.
Satellite cells and Schwann cells upregulated ATF3 follow-
ing paclitaxel treatment (Peters et al., 2007a,b) which induced a
peripheral neuropathy. Such expression may, of course, be the
result of damage to the axons or direct effects on the glia. An
early and signiﬁcant observation was that, following dorsal root
injury, ATF3 upregulation by glia around the degenerating axons
within the CNS was less than that by glial cells around the same
degenerating axons within the dorsal root (Hunt et al., 2004), i.e.,
ATF3 was upregulated by glia where axonal regeneration normally
occurs but upregulated to amuch lesser extentwhere axonal regen-
eration does not occur. The implication of this is that the changes
in gene expression mediated by ATF3 in glia may be crucial to
providing an environment suitable for regenerating axons.
The speciﬁc role of glial ATF3, upregulated after axonal injury,
is subject of ongoing debate. In transformed mammary epithe-
lial cells ATF3 enhanced ﬁbronectin expression (Yin et al., 2010),
which may exert a growth-promoting effect (Vogelezang et al.,
1999). In untransformed chick ﬁbroblasts ATF3 also repressed the
expression of decorin (Perez et al., 2001; Yin et al., 2010), a TGFb-
binding glycoproteinwhichmay reduce scarring and thus promote
regeneration (Davies et al., 2004). But to determine a speciﬁc role
for ATF3 in glia, one would probably need a cell type-speciﬁc
deletion of most of the ATF3 gene encompassing exons C to E,
which encode all the bZip domain and large part of the repressor
region.
ATF3 in neuroinﬂammation
Inﬂammation in theCNSprovides a stimulus for glialATF3 upreg-
ulation. ATF3 can be induced in macrophages and microglia by
the cytokine, IL6 (Dominguez et al., 2010). Lipopolysaccharide, a
highly inﬂammatory bacterial product, applied to the motor cor-
tex inducedATF3 expression in the nuclei of many glial cells in the
subcortical white matter (Hossain-Ibrahim et al., 2006). ATF3 is a
negative regulator of TLR4, the receptor for lipopolysaccharide in
such cells (Gilchrist et al., 2006) and as such might be expected to
dampen down the inﬂammatory response of microglia.
Activating transcription factor 3 is also induced in neurons in
some inﬂammatory states: ATF3 is upregulated in the inﬂamed
spinal cord of animals with CCI of the sciatic nerve (see above
and Dominguez et al., 2010) and in the pontine nuclei follow-
ing demyelination of the pontocerebellar tract. In a patient with
Marburg’s variant of multiple sclerosis ATF3 was found in neu-
rons within the pontine nuclei and neocortex (Lovas et al., 2010).
A caveat is that the extent of axonal injury in such cases of
demyelination remains unknown.
Neuroinﬂammation has been hypothesized to play a role in
the genesis of some psychiatric conditions (Smith, 1992). ATF3
expression bymonocyteswas increased in schizophrenia and bipo-
lar disorder (Drexhage et al., 2010;Weigelt et al., 2011).ATF3 binds
to the triggering receptor expressed on myeloid cells 1 (TREM-1)
promoter and may be a negative regulator of the inﬂammatory
response (Weigelt et al., 2011) but it is not clear how this would ﬁt
in to the pathology of psychoses.
WHAT IS THE FUNCTION OF NEURONAL ATF3?
Activating transcription factor 3hasnoknownrole inneural devel-
opment or the intact nervous system; its expression appears to be
to a response stimuli which are mainly stressful or pathological
(Tables 1 and 2). Most direct evidence in terms of functional
role comes from experiments with transgenic mice. Transgenic
mice that overexpress ATF3 in sensory dorsal root ganglion neu-
rons show enhanced rate of sensory axon regeneration following
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Table 1 | Genes and signaling pathways related to axonal regeneration that are regulated by ATF3.
Upregulated by ATF3 Downregulated by ATF3 Significance for axonal regeneration
Fibronectin (Yin et al., 2008) in
mammary epithelial cells
Fibronectin is produced by Schwann cells and promotes
neurite outgrowth (Tucker and Mearow, 2008)
Toll-like receptor signaling (Gilchrist
et al., 2006; Litvak et al., 2009) in
immune cells
Inﬂammation around neuronal cell bodies is correlated
with andmay stimulate axonal regeneration (Leon et al.,
2000; Shokouhi et al., 2010)
Decorin (Perez et al., 2001) in
embryonic chick ﬁbroblasts
Decorin reduces scar formation in the CNS and
enhances axonal regeneration (Davies et al., 2004;
Minor et al., 2008)
Thrombospondin 2 (Perez et al.,
2001) in embryonic chick ﬁbroblasts
Thrombospondin-deﬁcient mice show axonal sprouting
deﬁcits (Liauw et al., 2008)
SPRR1A (Seijffers et al., 2007) in neurons Promotes neurite outgrowth (Bonilla et al., 2002)
Hsp27 (Seijffers et al., 2007) in neurons Expression is associated with axonal regeneration
(Williams et al., 2006)
c-Jun (Seijffers et al., 2007) in neurons Important regulator of axonal regeneration (Raivich
et al., 2004)
DINE (Kiryu-Seo et al., 2008) in neurons Required for neuromuscluar junction formation and
sprouting of motor axons (Nagata et al., 2010)
sciatic nerve injury (Seijffers et al., 2007). This is accompanied by
increased expression of the genes for the regeneration-associated
molecule SPRR1A (which, like ATF3, is not found in neurons dur-
ing developmental axonal growth), hsp27, c-Jun, and CAP-23 but
not for the prototype growth-associated molecule GAP43 or the
regeneration-related transcription factor, STAT3. In vitro, ATF3
overexpression induces the growth of longer, less branched neu-
rites from DRG neurons (Seijffers et al., 2006). Unlike peripheral
injury, ATF3 overexpression alone also does not produce a pro-
nounced cell body response comparable to that observed following
injury to the peripheral axon.
Activating transcription factor 3 frequently exerts a supplemen-
tary function. Co-transfection of ATF3 and c-Jun into neuronal
cell lines produced greater neurite outgrowth than transfection
with individual genes (Pearson et al., 2003). Using Sp1 as a scaf-
fold, ATF3 interacts with at least three other transcription factors,
C/EBP, c-Jun, and STAT3 (Kiryu-Seo et al., 2008), each of which
has been shown to be important in axonal regeneration (Raivich
et al., 2004; Nadeau et al., 2005; Bareyre et al., 2011) and plays
an important role for the induction of expression of damage-
induced neuronal endopeptidase (DINE) in a neuroblastoma cell
line (Kiryu-Seo et al., 2008). DINE is necessary for the branch-
ing of motor neuron axons within muscle during development
and the formation of adequate neuromuscular junctions (Nagata
et al., 2010).
In the absence of other transcription factors found in regen-
erating neurons (e.g., c-Jun, STAT3), the overexpression of ATF3
has relatively modest effects. For example, it is not sufﬁcient to
allow DRG axons to regenerate in the presence of CNS myelin
in vitro or in the injured spinal cord in vivo. Moreover, deletion of
gp130, a component of the commonneurokine receptor, upstream
of STAT3 phosphorylation (Habecker et al., 2009), abolishes the
conditioning lesion response in explanted, sympathetic neurons,
even though ATF3 is still upregulated (Hyatt-Sachs et al., 2010).
One apparent anomaly is that inﬂammation-related genes,
which are typically downregulated by ATF3 in cells of the immune
system,are upregulated in sensory and autonomic ganglia contain-
ing axotomized (and regenerating) neurons (Costigan et al., 2002;
Boeshore et al., 2004). Inﬂammatory responses around neurons
are positively correlated with axonal regeneration (Shokouhi et al.,
2010) and the generation of inﬂammation around neuronal cell
bodies has been shown to enhance regeneration of axons (Lu and
Richardson,1991;Yin et al., 2003). It is possible that either the tran-
scriptional network in axotomized neurons ameliorates the effects
of ATF3 on inﬂammatory genes or that one function of ATF3
expression in regenerating neurons is to limit the inﬂammatory
response, preventing neuronal cell death.
Overexpression of ATF3 is frequently neuroprotective, proba-
bly by acting as a transcriptional repressor. In vitro, delivery of
ATF3 to sympathetic neurons with a viral vector (Nakagomi et al.,
2003) reduced cell death resulting from growth factor depriva-
tion and enhanced neurite outgrowth, by a pathway involving
Hsp27 and Akt activation, and requiring c-Jun. Similar neuropro-
tective effect, this time from kainite-induced excitotoxic cell death,
is also observed in the hippocampal CA1 region (Francis et al.,
2004). ATF3 reduces brain damage following a cerebral ischemic
insult in mice, acting as a transcriptional repressor (Zhang et al.,
2011). Overexpression of ATF3 had neuroprotective effects on
PC12 cells expressing mutant Huntingtin, whereas knock down
of ATF3 increased toxicity (Liang et al., 2009).
AnATF3“knockout”mousehas beenused inmany experiments
tohelpdetermine the functionofATF3 inbiological processes,par-
ticularly stress responses and cancer (Hartman et al., 2004; Khuu
et al., 2007;Akram et al., 2010; Zmuda et al., 2010). The mouse was
generated by replacement of exon B, containing the start codon,
with a neomycin resistance gene expressed from the reverse strand
(Hartman et al., 2004). The animal has no reported defects in the
development of the nervous system, a result which concurs with
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Table 2 | Genes and signaling pathways regulated by ATF3 that are potentially related to neuronal death/neuroprotection.
Upregulated by ATF3 Downregulated by ATF3 Significance for neuroprotection
Death receptor 5 (DR5) in colonic cancer cells
(Taketani et al., 2011)
Binding of its ligand causes DR5 to trigger cell
death
DR5 and BBC3/PUMA in stressed colorectal
cancer cells (Tanaka et al., 2011)
TNFRSF10B/DR5 and BBC3/PUMA in prostate
cancer cells (Tanaka et al., 2011)
DR5 and BBC3/PUMA are pro-apoptotic
genes (Tanaka et al., 2011)
STAT1 in pancreatic beta cells is induced and
stabilized by ATF3 (Kim et al., 2010a)
STAT1 is involved in beta cell apoptosis in
response to streptozotocin (Rasschaert et al.,
2005)
Inhibition of differentiation-1 (Id-1;
Kashiwakura et al., 2008)
ID-1 downregulation is associated with cell
death in cancer cells (Wong et al., 2008)
Hsp27 (Seijffers et al., 2007) in neurons Protects neurons from cell death following
various insults (Lewis et al., 1999)
CHOP/GADD153 in mouse ﬁbroblasts subject
to leucine starvation (Jiang et al., 2004)
CHOP/GADD153 expression is known to
induce cell cycle arrest and apoptosis in
response to cellular stress factors and is also
known to promote apoptosis of cancer cell
lines (Maytin et al., 2001)
CHOP/GADD153 (Wolfgang et al., 1997) in
HeLa cells
See above
CHOP/GADD153 levels in 6-OHDA – treated
dopaminergic neurons are partially dependent
on ATF3 (Bernstein et al., 2011)
See above
p53 is stabilized in ﬁbroblast cell lines by ATF3
(Yan et al., 2005)
P53 can activate DNA repair or initiate apop-
tosis. Its expression is linked to cell death in
ischemic brain injury (Hong et al., 2010).
Axonal transport of mitochondria (Kiryu-Seo
et al., 2010)
The knockdown of ATF3 increased signs of
mitochondrial damage in axons (Kiryu-Seo
et al., 2010). Mitochondrial misfunction is
important for axonal pathology in multiple
sclerosis (Smith et al., 1999)
IRS2 in pancreatic beta cells (Li et al., 2008) IRS2 is anti-apoptotic in beta cells (Li et al.,
2008)
NRF2 in mouse mammary epithelial cells NRF2 helps cells from Parkinson’s disease
patients to resist oxidative stress (Cook et al.,
2011) and its absent enhances the damage
caused by MTPT (Innamorato et al., 2010)
c-Jun (Seijffers et al., 2007) in neurons Important regulator of neuronal survival fol-
lowing axotomy (Raivich et al., 2004)
ATF3ΔZip2 indirectly attenuates the
anti-apoptotic effects of NF-κB signaling in
rodent cell lines by displacing a positive
cofactor from target genes (Hua et al., 2006)
Sample citations to indicate the signiﬁcance of individual genes/pathways are given. As can be seen from the cases of CHOP, DR5, and BBC3/PUMA, ATF3 can
regulate genes in opposite directions in different types of cells and under different conditions. Unfortunately, few of the data refer to neurons or glial cells.
the ﬁnding that ATF3 is not expressed in the developing mouse
cortex at embryonic day 15.5 (Dr S. Rakic, UCL, unpublished
microarray data) when such events are underway.
Preliminary experiments on sciatic nerve regeneration using
ATF3 mutants (Hossein-Ibrahim, unpublished) showed no sig-
niﬁcant difference in the time taken for the return of the toe
spreading reﬂex or the return of the response to the von Frey hair
stimulation of the footpad compared to that in control animals.
Studies of neurite outgrowth fromDRGneurons in vitro also show
no obvious defect (Seijffers et al., 2006). Interestingly, ATF3 can
still be detected in the nuclei of denervated Schwann cells and
injured neurons using a commercially available antibody from
Santa Cruz Biotechnology (Seijffers et al., 2006; Hossein-Ibrahim,
Mason and Anderson, unpublished). This suggests that parts of
the ATF3 protein, including those required for nuclear localiza-
tion, are still expressed and coincides with a presence of a 17-kDa
ATF3-immunoreactive protein on Western Blots (Seijffers et al.,
2006). However, it is uncertain whether this was a truncated form
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of ATF3 and, if so, whether it retains biological activity. It is not
clear how an in-frame sequence can be generated when exon B is
eliminated from the mouse ATF3 gene. The mutation has effects
in non-neural cells (Hartman et al., 2004; Jiang et al., 2004; Whit-
more et al., 2007; Akram et al., 2010). In some of these studies
ATF3 has been reported to be absent from Western blots of the
mutant cells, even with the Santa Cruz antibody (Hartman et al.,
2004; Jiang et al., 2004). However, to our knowledge, no stud-
ies which have reported a phenotype for the mutant cells have
reported immunohistochemically detectable ATF3 in cell nuclei,
as is the case for injured neurons and Schwann cells. There is one
report (Bernstein et al., 2011) of effects of the mutation on cul-
tured neurons (CHOP levels were reduced in 6-OHDA – treated
dopaminergic neurons) but the preliminary data make it unlikely
that any effects of this mutation on axonal regeneration will be
profound.
CONCLUSION
Although ATF3 is now widely used as marker for axotomized neu-
rons, the complex interactions of ATF3 with other transcription
factors make an assessment of its role in the injured nervous sys-
temdifﬁcult.ATF3has been shown to be an adaptive response gene
which allows cell death and cell cycle pathways in non-neuronal
cells to bemodulated toproduce an appropriate response tomainly
stressful stimuli. Its expression in many tissues is associated with
tissue dysfunction and disease progression (Hai, 2006) but in
neurons its expression is usually correlated with the responses to
injury that lead to axonal regeneration and neuroprotection. One
problem with understanding the role of ATF3 in the nervous sys-
tem is that most studies of ATF3 function have been carried out
on cultured non-neuronal cells or neuronal cell lines. It is not all
clear whether ATF3 will have the same functions in such cells as in
post-mitotic neurons.
The difﬁculties with the existing strain of knockout mice (Sei-
jffers et al., 2006) have delayed a full evaluation of the role of ATF3
in the nervous system in vivo and the status of ATF3 expression
in those animals requires clariﬁcation. Other gain of function and
loss of function studies have demonstrated a modest role for ATF3
in driving the expression of other growth-related and neuropro-
tective genes but the generation of more sophisticated conditional
knockouts in neurons, glial cells, and immune system cells will
be required to elucidate all the functions of ATF3 in the nervous
system.
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